Successful antiviral treatment of chronic hepatitis C in patients with rare comorbidities. Two case-reports
Journal Title: Annals of Hepatology - Year 2012, Vol 11, Issue 3
Abstract
Antiviral therapy in patients suffering from chronic hepatitis C virus (HCV) infection and rare comorbidities cannot be easily started, as it can reduce the likelihood of a good therapeutic response with an increased frequency of side effects. We report two patients presenting unusual comorbidities associated with chronic C hepatitis: one with the Ehlers-Danlos Syndrome (EDS), a rare genetic disease caused by a defect in collagen synthesis, the other one with the Charcot Marie Tooth (CMT) disease, an uncommon but severe form of demyelinating peripheral neuropathy. Both patients were successfully treated with pegylated Interferon (Peg-IFN) and ribavirin (RBV) combined therapy, with the achievement of a sustained viral response (SVR) and a low occurrence of adverse effects. Up to now there are no reports of patients suffering from chronic C hepatitis associated with these uncommon but severe comorbidities treated with antiviral therapy. In conclusion, in such clinical situations, anti-HCV therapy may be started and tailored, especially if the patient is highly motivated and if optimal predictors of response (i.e. young age, favourable genotype and low baseline viraemia) do exist.
Authors and Affiliations
Viola Guardigni, Gabriele Fabbri, Anastasio Grilli, Carlo Contini
Keywords
Related Articles
- EP ID EP78155
- DOI -
- Views 114
- Downloads 0
Spontaneous bacterial peritonitis caused by Listeria monocytogenes: a case report and literature review
Spontaneous bacterial peritonitis (SBP) is a common and often serious complication of long standing ascites in the presence of advanced liver disease.1 We report a case of a 51- year-old man with alcoholic cirrhosis admi...
Albumin dialysis with MARS for the treatment of anabolic steroid-induced cholestasis
Background and aims. Steroid-related hepatotoxicity has become one of the most relevant causes of drug induced livercholestasis. Some patients do not improve after standard medical treatment (SMT) and may therefore requ...
Prevalence and resistance pattern of genotype G and H in chronic hepatitis B and HIV co-infected patients in Mexico
Objective. We estimated the prevalence and identified the resistance pattern of HBV genotypes H and G in HBV monoinfected and HIV co-infected patients. Material and methods. A cross-sectional prevalence and analytic stud...
Cardiac changes and liver disease
Survey of health status, nutrition and geography of food selection of chronic liver disease patients
Background. Obesity, a complex disease determined both by genetic and environmental factors, is strongly associated with NAFLD, and has been demonstrated to have a negative impact on HCV and other chronic liver diseases...